Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
about
The balance of powers: Redox regulation of fibrogenic pathways in kidney injurySimilarity in Transcytosis of nNOSα in Enteric Nerve Terminals and Beta Cells of Pancreatic IsletNew Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.Mechanisms of disease: the oxidative stress theory of diabetic neuropathyQuantitative analysis of amino Acid oxidation markers by tandem mass spectrometryPhenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes modelDecreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.Effect of pioglitazone on nerve conduction velocity of the median nerve in the carpal tunnel in type 2 diabetes patients.Inflammation as a Therapeutic Target for Diabetic Neuropathies.Mouse models of diabetic neuropathy.Hyperlipidemia: a new therapeutic target for diabetic neuropathy.Diabetic neuropathy: cellular mechanisms as therapeutic targets.Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis.Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.
P2860
Q26786137-49FCDB10-6F24-4618-9514-0AF672CF2952Q28085023-1C90D33C-39FF-41D3-A37A-1B9475173939Q30235132-180AAA58-A2EA-4A26-A56D-D183E3A23BC9Q33571558-035578F5-4ED9-4FFC-8990-B04DB8AA82C2Q34135732-8C7D3E87-9A8E-4AA9-8C10-08FE97E430D7Q34553052-162AC227-5E50-42A7-8E8A-5FF1F86E6B48Q35173711-99DBF4FE-23CE-40D3-BF28-A5375DF7C534Q35579658-7B3B3F03-FD4F-4789-99E4-D8440E8E4238Q36293649-ED68C52C-09DC-467C-AB4C-1D7028C6D878Q36477207-8D9A7CF8-4D79-472D-BB0E-9462E6B5F162Q36535440-5EB1B055-24FA-44AD-A73E-756CBA35A883Q36879268-7DB83165-4428-4E87-8FF6-D7A8F48FF60EQ36889267-72674AF4-2DD6-4C00-9BC3-9E1F23576FAAQ37168753-EB044443-92E2-48E8-A9A8-22DADD195E8EQ37193699-82ACCB17-20E0-4BCD-9DFA-820B7D7CA046Q37360464-34A7019A-C6D2-4519-9EE5-879B64FDBFE3Q37411532-F9E85CE6-8E3E-4BF4-A2C9-33ADD41C8941Q37450547-2EE4463C-A7A1-465B-86E0-840B47EBAF51Q37655239-8EE73998-EE00-41C8-9EC0-5D5B6DB9CCFFQ37659233-B5C3BCEB-162D-4D0E-A68C-E37D272085D9Q37930962-3AE42519-0BD4-450A-8B5F-B3CAD918EBD3Q38319146-374DE9D7-E6DB-4FFA-9FE5-19E1EBD5470FQ47380940-9360792D-F22B-4DAF-B207-18AFCB8DEB11Q52650664-02D3EF0E-5A19-4299-AC27-26EA5A2D563BQ53295371-584C73C4-C56F-4ACE-821A-6E0E26FAFDDD
P2860
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
@en
type
label
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
@en
prefLabel
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
@en
P2093
P2860
P356
P1433
P1476
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
@en
P2093
Eva L Feldman
Frank C Brosius
Kelli A Sullivan
Matthias Kretzler
Subramaniam Pennathur
Timothy D Wiggin
P2860
P304
P356
10.1210/EN.2008-0869
P407
P577
2008-06-26T00:00:00Z